LENZ Therapeutics Inc. (LENZ)
LENZ Therapeutics Statistics
Share Statistics
LENZ Therapeutics has 28.15M shares outstanding. The number of shares has increased by 7.87% in one year.
| 28.15M |
| 7.87% |
| 0.15% |
| 71.26% |
| n/a |
| 2,785 |
| 1.13% |
Short Selling Information
The latest short interest is 3.38M, so 12% of the outstanding shares have been sold short.
| 3.38M |
| 12% |
| 22.47% |
| 15.39 |
Valuation Ratios
The PE ratio is -12.34 and the forward PE ratio is -10.62. LENZ Therapeutics's PEG ratio is 0.15.
| -12.34 |
| -10.62 |
| 0 |
| 2.7 |
| 3.01 |
| -10.26 |
| 0.15 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for LENZ Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 20.36, with a Debt / Equity ratio of 0.01.
| 20.36 |
| 20.36 |
| 0.01 |
| -0.03 |
| -0.02 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-8,294,833.33 |
| 6 |
| 0 |
| n/a |
Taxes
| 1K |
| 0% |
Stock Price Statistics
The stock price has increased by 105.13% in the last 52 weeks. The beta is 0.41, so LENZ Therapeutics's price volatility has been higher than the market average.
| 0.41 |
| 105.13% |
| 26.39 |
| 26.6 |
| 66.35 |
| 246,328 |
Balance Sheet
The company has 20.16M in cash and 1.38M in debt, giving a net cash position of 18.78M.
| 20.16M |
| 1.38M |
| 18.78M |
| -145.01M |
| 201.25M |
| 189.29M |
Cash Flow
In the last 12 months, operating cash flow was -59.39M and capital expenditures -468K, giving a free cash flow of -59.86M.
| -59.39M |
| -468K |
| -59.86M |
| -2.81 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
LENZ does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for LENZ is $42.5, which is 33% higher than the current price. The consensus rating is "Buy".
| $42.5 |
| 33% |
| Buy |
| 4 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Mar 22, 2024. It was a backward split with a ratio of 1:7.
| Mar 22, 2024 |
| backward |
| 1:7 |
Scores
| 53.32 |
| 1 |